Symbols / IVF $2.20 -8.33% INVO Fertility, Inc.
IVF Chart
About
INVO Fertility, Inc., a healthcare services company, focuses on the fertility marketplace that provides assisted reproductive technology care to patients. It operates through Fertility Clinic Services; INVOcell Device; and Therapeutics segments. The company offers INVOcell Device, a medical device that allows fertilization and early embryo development to take place in vivo within the woman's body. It also operates fertility clinics, including INVO Centers. In addition, the company develops NY-303, a GPC3 x NKp46 bifunctional antibody that is in Phase i/ii a monotherapy trial for the treatment of hepatocellular carcinoma; and NY-500, an AI-optimized bifunctional antibody. The company was formerly known as NAYA Biosciences, Inc. and changed its name to INVO Fertility, Inc. in April 2025. INVO Fertility, Inc. was founded in 2007 and is based in Sarasota, Florida.
Fundamentals
Scroll to Statements| Sector | Healthcare | Industry | Medical Devices | Market Cap | 15.31M |
| Enterprise Value | 13.70M | Income | -11.22M | Sales | 6.94M |
| Book/sh | -22.34 | Cash/sh | 0.94 | Dividend Yield | — |
| Payout | 0.00% | Employees | 33 | IPO | — |
| P/E | — | Forward P/E | -0.09 | PEG | — |
| P/S | 2.21 | P/B | -0.10 | P/C | — |
| EV/EBITDA | -1.93 | EV/Sales | 1.97 | Quick Ratio | 0.07 |
| Current Ratio | 0.12 | Debt/Eq | 72.39 | LT Debt/Eq | — |
| EPS (ttm) | -1474.40 | EPS next Y | -23.20 | EPS Growth | — |
| Revenue Growth | 22.60% | Earnings | 2025-04-30 09:00 | ROA | -48.36% |
| ROE | — | ROIC | — | Gross Margin | 39.17% |
| Oper. Margin | -93.08% | Profit Margin | 0.00% | Shs Outstand | 6.96M |
| Shs Float | 345.11K | Short Float | 4.80% | Short Ratio | 0.41 |
| Short Interest | — | 52W High | 384.00 | 52W Low | 2.15 |
| Beta | — | Avg Volume | 1.46M | Volume | 45.61K |
| Target Price | $20.00 | Recom | None | Prev Close | $2.40 |
| Price | $2.20 | Change | -8.33% |
Valuation Models
Price estimates from analyst targets and simple models.
Ratings
News
RSS: Latest IVF news- INVO Fertility stock becomes 1 share for every 5 on March 27 - Stock Titan Wed, 25 Mar 2026 07
- INVO Fertility, Inc. Announces 1-for-5 Reverse Stock Split Effective March 27, 2026 - Quiver Quantitative Wed, 25 Mar 2026 07
- A Little-Known Fertility Stock Soared 350% — Here’s What Traders Are Watching - stocktwits.com hu, 05 Mar 2026 08
- INVO Fertility stock soars after shareholders approve share increase - Investing.com ue, 27 Jan 2026 08
- INVO Fertility Announces 1-for-5 Reverse Stock Split - TipRanks Wed, 01 Apr 2026 03
- Glenbrook Capital holds 134,515 shares of INVO Fertility (NASDAQ: IVF) filing - Stock Titan Wed, 01 Apr 2026 20
- INVO Fertility announces 1-for-5 reverse stock split - Investing.com Wed, 25 Mar 2026 07
- Why Is INVO Fertility Stock (IVF) Up Today? - TipRanks ue, 20 Jan 2026 08
- INVO Fertility (NASDAQ: IVF) completes 1-for-5 reverse stock split - Stock Titan ue, 31 Mar 2026 20
- $IVF stock is up 322% today. Here's what we see in our data. - Quiver Quantitative ue, 20 Jan 2026 08
- INVO Fertility stock soars after planned acquisition of Indiana clinic - Investing.com Fri, 28 Nov 2025 08
- INVO Fertility (NASDAQ: IVF) requests 15-day extension to file 2025 Form 10-K - Stock Titan Wed, 01 Apr 2026 12
- INVO Fertility, Inc. Announces 1-for-8 Reverse Stock Split Effective November 28, 2025 | IVF Stock News - Quiver Quantitative ue, 25 Nov 2025 08
- IVF SEC Filings - INVO Fertility, Inc 10-K, 10-Q, 8-K Forms - Stock Titan ue, 31 Mar 2026 19
- INVO Fertility, Inc. Announces Strategic Outlook for Growth and Strengthened Financial Position - Quiver Quantitative Wed, 04 Feb 2026 08
Financials
| Line Item | Trend | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue |
|
6.53
+116.25%
|
3.02
+267.38%
|
0.82
-80.24%
|
4.16
|
| Operating Revenue |
|
6.53
+116.25%
|
3.02
+267.38%
|
0.82
-80.24%
|
4.16
|
| Cost Of Revenue |
|
3.66
+89.09%
|
1.93
+127.37%
|
0.85
+486.53%
|
0.15
|
| Reconciled Cost Of Revenue |
|
3.66
+89.09%
|
1.93
+127.37%
|
0.85
+486.53%
|
0.15
|
| Gross Profit |
|
2.87
+164.63%
|
1.09
+3901.14%
|
-0.03
-100.71%
|
4.02
|
| Operating Expense |
|
10.49
+33.55%
|
7.85
-25.90%
|
10.60
+14.80%
|
9.23
|
| Research And Development |
|
0.49
+195.07%
|
0.17
-69.50%
|
0.54
+151.37%
|
0.22
|
| Selling General And Administration |
|
9.08
+21.27%
|
7.49
-24.96%
|
9.98
+10.66%
|
9.02
|
| Total Expenses |
|
14.15
+44.53%
|
9.79
-14.51%
|
11.45
+22.10%
|
9.38
|
| Operating Income |
|
-7.61
-12.51%
|
-6.77
+36.32%
|
-10.63
-103.71%
|
-5.22
|
| Total Operating Income As Reported |
|
-8.13
-20.07%
|
-6.77
+36.32%
|
-10.63
-103.71%
|
-5.22
|
| EBITDA |
|
-7.14
-3.82%
|
-6.88
+36.02%
|
-10.75
-106.04%
|
-5.22
|
| Normalized EBITDA |
|
-6.69
-0.89%
|
-6.63
+38.35%
|
-10.75
-100.01%
|
-5.37
|
| Reconciled Depreciation |
|
0.92
+357.76%
|
0.20
+159.89%
|
0.08
-53.46%
|
0.17
|
| EBIT |
|
-8.06
-13.86%
|
-7.08
+34.62%
|
-10.83
-101.12%
|
-5.38
|
| Total Unusual Items |
|
-0.46
-80.52%
|
-0.25
-7220.01%
|
-0.00
-102.23%
|
0.16
|
| Total Unusual Items Excluding Goodwill |
|
-0.46
-80.52%
|
-0.25
-7220.01%
|
-0.00
-102.23%
|
0.16
|
| Special Income Charges |
|
-0.46
-80.82%
|
-0.25
|
0.00
-100.00%
|
0.16
|
| Other Special Charges |
|
-0.05
-133.11%
|
0.16
|
—
|
-0.16
|
| Write Off |
|
0.00
-100.00%
|
0.09
|
0.00
|
—
|
| Net Income |
|
-9.10
-13.21%
|
-8.03
+26.24%
|
-10.89
-63.68%
|
-6.65
|
| Pretax Income |
|
-9.12
-13.89%
|
-8.01
+26.47%
|
-10.89
-63.75%
|
-6.65
|
| Net Non Operating Interest Income Expense |
|
-1.06
-14.09%
|
-0.93
-1465.70%
|
-0.06
+95.31%
|
-1.26
|
| Interest Expense Non Operating |
|
1.06
+14.09%
|
0.93
+1457.59%
|
0.06
-95.30%
|
1.27
|
| Net Interest Income |
|
-1.06
-14.09%
|
-0.93
-1465.70%
|
-0.06
+95.31%
|
-1.26
|
| Interest Expense |
|
1.06
+14.09%
|
0.93
+1457.59%
|
0.06
-95.30%
|
1.27
|
| Interest Income Non Operating |
|
—
|
0.00
-100.00%
|
0.00
-91.58%
|
0.00
|
| Interest Income |
|
—
|
0.00
-100.00%
|
0.00
-91.58%
|
0.00
|
| Other Income Expense |
|
-0.45
-42.96%
|
-0.31
-53.79%
|
-0.20
-18.65%
|
-0.17
|
| Gain On Sale Of Security |
|
—
|
-0.00
+87.87%
|
-0.00
+2.01%
|
-0.00
|
| Tax Provision |
|
-0.02
-182.46%
|
0.03
+867.48%
|
0.00
-39.71%
|
0.00
|
| Tax Rate For Calcs |
|
0.00
-98.81%
|
0.00
+0.00%
|
0.00
-22.22%
|
0.00
|
| Tax Effect Of Unusual Items |
|
-0.00
+97.85%
|
-0.05
-7220.01%
|
-0.00
-101.73%
|
0.04
|
| Net Income Including Noncontrolling Interests |
|
-9.10
-13.21%
|
-8.03
+26.24%
|
-10.89
-63.68%
|
-6.65
|
| Net Income From Continuing Operation Net Minority Interest |
|
-9.10
-13.21%
|
-8.03
+26.24%
|
-10.89
-63.68%
|
-6.65
|
| Net Income From Continuing And Discontinued Operation |
|
-9.10
-13.21%
|
-8.03
+26.24%
|
-10.89
-63.68%
|
-6.65
|
| Net Income Continuous Operations |
|
-9.10
-13.21%
|
-8.03
+26.24%
|
-10.89
-63.68%
|
-6.65
|
| Normalized Income |
|
-8.64
-10.28%
|
-7.83
+28.06%
|
-10.89
-60.89%
|
-6.77
|
| Net Income Common Stockholders |
|
-9.35
-16.33%
|
-8.03
+26.24%
|
-10.89
-63.68%
|
-6.65
|
| Otherunder Preferred Stock Dividend |
|
0.25
|
0.00
|
—
|
—
|
| Diluted EPS |
|
-3,622.80
+21.99%
|
-4,644.28
+82.01%
|
-25,811.64
-60.57%
|
-16,074.73
|
| Basic EPS |
|
-3,622.80
+21.99%
|
-4,644.28
+82.01%
|
-25,811.64
-60.57%
|
-16,074.73
|
| Basic Average Shares |
|
0.00
+49.08%
|
0.00
+309.95%
|
0.00
+1.93%
|
0.00
|
| Diluted Average Shares |
|
0.00
+49.08%
|
0.00
+309.95%
|
0.00
+1.93%
|
0.00
|
| Diluted NI Availto Com Stockholders |
|
-9.35
-16.33%
|
-8.03
+26.24%
|
-10.89
-63.68%
|
-6.65
|
| Depreciation Amortization Depletion Income Statement |
|
0.92
+357.76%
|
0.20
+159.89%
|
0.08
|
—
|
| Depreciation And Amortization In Income Statement |
|
0.92
+357.76%
|
0.20
+159.89%
|
0.08
|
—
|
| Earnings From Equity Interest |
|
0.01
+115.01%
|
-0.06
+69.95%
|
-0.20
+38.77%
|
-0.33
|
| Gain On Sale Of PPE |
|
-0.51
|
0.00
|
—
|
—
|
| Line Item | Trend | 2023-12-31 |
|---|---|---|
| Total Assets |
|
18.51
|
| Current Assets |
|
1.26
|
| Cash Cash Equivalents And Short Term Investments |
|
0.23
|
| Cash And Cash Equivalents |
|
0.23
|
| Cash Financial |
|
0.23
|
| Receivables |
|
0.14
|
| Accounts Receivable |
|
0.14
|
| Inventory |
|
0.26
|
| Raw Materials |
|
0.05
|
| Work In Process |
|
—
|
| Finished Goods |
|
0.21
|
| Prepaid Assets |
|
—
|
| Other Current Assets |
|
0.62
|
| Total Non Current Assets |
|
17.25
|
| Net PPE |
|
4.19
|
| Gross PPE |
|
4.42
|
| Accumulated Depreciation |
|
-0.23
|
| Properties |
|
0.00
|
| Machinery Furniture Equipment |
|
0.09
|
| Other Properties |
|
3.80
|
| Leases |
|
0.54
|
| Goodwill And Other Intangible Assets |
|
9.97
|
| Goodwill |
|
5.88
|
| Other Intangible Assets |
|
4.09
|
| Investments And Advances |
|
3.09
|
| Long Term Equity Investment |
|
3.09
|
| Total Liabilities Net Minority Interest |
|
17.61
|
| Current Liabilities |
|
8.00
|
| Payables And Accrued Expenses |
|
4.83
|
| Payables |
|
4.83
|
| Accounts Payable |
|
2.33
|
| Other Payable |
|
2.50
|
| Pensionand Other Post Retirement Benefit Plans Current |
|
0.72
|
| Total Tax Payable |
|
—
|
| Income Tax Payable |
|
—
|
| Current Debt And Capital Lease Obligation |
|
1.69
|
| Current Debt |
|
1.51
|
| Other Current Borrowings |
|
0.63
|
| Current Capital Lease Obligation |
|
0.18
|
| Current Deferred Liabilities |
|
0.41
|
| Current Deferred Revenue |
|
0.41
|
| Other Current Liabilities |
|
0.35
|
| Total Non Current Liabilities Net Minority Interest |
|
9.61
|
| Long Term Debt And Capital Lease Obligation |
|
4.61
|
| Long Term Debt |
|
1.25
|
| Long Term Capital Lease Obligation |
|
3.36
|
| Tradeand Other Payables Non Current |
|
5.00
|
| Non Current Deferred Liabilities |
|
0.00
|
| Non Current Deferred Revenue |
|
—
|
| Non Current Deferred Taxes Liabilities |
|
0.00
|
| Other Non Current Liabilities |
|
0.00
|
| Preferred Securities Outside Stock Equity |
|
0.00
|
| Stockholders Equity |
|
0.89
|
| Common Stock Equity |
|
-5.11
|
| Capital Stock |
|
6.00
|
| Common Stock |
|
0.00
|
| Preferred Stock |
|
6.00
|
| Share Issued |
|
0.00
|
| Ordinary Shares Number |
|
0.00
|
| Treasury Shares Number |
|
0.00
|
| Additional Paid In Capital |
|
52.71
|
| Retained Earnings |
|
-57.82
|
| Total Equity Gross Minority Interest |
|
0.89
|
| Total Capitalization |
|
2.15
|
| Working Capital |
|
-6.74
|
| Invested Capital |
|
-2.34
|
| Total Debt |
|
6.30
|
| Net Debt |
|
2.53
|
| Capital Lease Obligations |
|
3.54
|
| Net Tangible Assets |
|
-9.08
|
| Tangible Book Value |
|
-15.08
|
| Current Notes Payable |
|
0.88
|
| Investmentsin Joint Venturesat Cost |
|
0.92
|
| Investmentsin Subsidiariesat Cost |
|
2.17
|
| Preferred Stock Equity |
|
6.00
|
| Line Item | Trend | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Operating Cash Flow |
|
-2.97
+37.45%
|
-4.76
+27.99%
|
-6.60
-9.51%
|
-6.03
|
| Cash Flow From Continuing Operating Activities |
|
-2.97
+37.45%
|
-4.76
+27.99%
|
-6.60
-9.51%
|
-6.03
|
| Net Income From Continuing Operations |
|
-9.10
-13.21%
|
-8.03
+26.24%
|
-10.89
-63.68%
|
-6.65
|
| Depreciation Amortization Depletion |
|
0.92
+357.76%
|
0.20
+159.89%
|
0.08
-53.46%
|
0.17
|
| Depreciation |
|
—
|
—
|
0.31
+84.44%
|
0.17
|
| Depreciation And Amortization |
|
0.92
+357.76%
|
0.20
+159.89%
|
0.08
-53.46%
|
0.17
|
| Other Non Cash Items |
|
1.21
+34.02%
|
0.90
+421.38%
|
0.17
-85.47%
|
1.19
|
| Stock Based Compensation |
|
1.59
+14.08%
|
1.39
-37.35%
|
2.22
-17.86%
|
2.71
|
| Asset Impairment Charge |
|
0.00
-100.00%
|
0.09
-32.09%
|
0.13
|
0.00
|
| Operating Gains Losses |
|
0.54
+142.95%
|
0.22
+11.46%
|
0.20
+19.08%
|
0.17
|
| Gain Loss On Sale Of PPE |
|
0.51
|
0.00
|
—
|
—
|
| Change In Working Capital |
|
1.86
+294.90%
|
0.47
-68.17%
|
1.48
+141.10%
|
-3.61
|
| Change In Receivables |
|
-0.03
+45.85%
|
-0.06
-137.64%
|
-0.03
+7.27%
|
-0.03
|
| Changes In Account Receivables |
|
-0.03
+45.85%
|
-0.06
-137.64%
|
-0.03
+7.27%
|
-0.03
|
| Change In Inventory |
|
0.04
+5043.98%
|
-0.00
-103.74%
|
0.02
+207.90%
|
-0.02
|
| Change In Prepaid Assets |
|
-0.16
+62.10%
|
-0.43
-566.88%
|
0.09
+174.15%
|
-0.12
|
| Change In Payables And Accrued Expense |
|
1.79
+117.88%
|
0.82
-35.24%
|
1.27
+840.71%
|
0.14
|
| Change In Accrued Expense |
|
0.44
+532.16%
|
-0.10
-127.90%
|
0.37
+1650.05%
|
0.02
|
| Change In Payable |
|
1.35
+46.07%
|
0.92
+2.28%
|
0.90
+692.32%
|
0.11
|
| Change In Account Payable |
|
1.35
+46.07%
|
0.92
+2.28%
|
0.90
+689.61%
|
0.11
|
| Change In Other Working Capital |
|
0.19
-32.53%
|
0.29
+149.98%
|
0.11
+103.27%
|
-3.51
|
| Change In Other Current Assets |
|
0.00
|
0.00
|
—
|
—
|
| Change In Other Current Liabilities |
|
0.03
+118.30%
|
-0.14
-2112.20%
|
0.01
+113.05%
|
-0.05
|
| Investing Cash Flow |
|
0.36
+114.59%
|
-2.49
-2971.87%
|
-0.08
+96.23%
|
-2.15
|
| Cash Flow From Continuing Investing Activities |
|
0.36
+114.59%
|
-2.49
-2971.87%
|
-0.08
+96.23%
|
-2.15
|
| Net PPE Purchase And Sale |
|
-0.11
+75.69%
|
-0.44
-4023.52%
|
-0.01
+97.41%
|
-0.42
|
| Purchase Of PPE |
|
-0.18
+58.69%
|
-0.44
-4023.52%
|
-0.01
+97.41%
|
-0.42
|
| Sale Of PPE |
|
0.08
|
0.00
|
—
|
—
|
| Capital Expenditure |
|
-0.18
+58.69%
|
-0.44
-3394.04%
|
-0.01
+97.20%
|
-0.45
|
| Net Business Purchase And Sale |
|
0.47
+123.02%
|
-2.05
-2893.41%
|
-0.07
+95.97%
|
-1.70
|
| Purchase Of Business |
|
0.00
+100.00%
|
-2.05
-2893.41%
|
-0.07
+95.97%
|
-1.70
|
| Net Intangibles Purchase And Sale |
|
—
|
0.00
+100.00%
|
-0.00
+95.01%
|
-0.04
|
| Purchase Of Intangibles |
|
—
|
0.00
+100.00%
|
-0.00
+95.01%
|
-0.04
|
| Financing Cash Flow |
|
3.12
-57.80%
|
7.39
+578.31%
|
1.09
-71.10%
|
3.77
|
| Cash Flow From Continuing Financing Activities |
|
3.12
-57.80%
|
7.39
+578.31%
|
1.09
-71.10%
|
3.77
|
| Net Issuance Payments Of Debt |
|
0.41
-75.38%
|
1.66
+108.11%
|
0.80
+420.00%
|
-0.25
|
| Issuance Of Debt |
|
1.34
-57.46%
|
3.16
+295.03%
|
0.80
|
0.00
|
| Repayment Of Debt |
|
-0.93
+37.51%
|
-1.50
|
0.00
+100.00%
|
-0.25
|
| Long Term Debt Issuance |
|
1.34
-57.46%
|
3.16
+295.03%
|
0.80
|
0.00
|
| Long Term Debt Payments |
|
-0.93
+37.51%
|
-1.50
|
0.00
+100.00%
|
-0.25
|
| Net Long Term Debt Issuance |
|
0.41
-75.38%
|
1.66
+108.11%
|
0.80
+420.00%
|
-0.25
|
| Short Term Debt Issuance |
|
0.00
-100.00%
|
0.10
-87.50%
|
0.80
|
0.00
|
| Short Term Debt Payments |
|
—
|
—
|
0.00
+100.00%
|
-0.25
|
| Net Short Term Debt Issuance |
|
0.00
-100.00%
|
0.10
-87.50%
|
0.80
+420.00%
|
-0.25
|
| Net Common Stock Issuance |
|
0.17
-97.10%
|
5.70
+1867.55%
|
0.29
-92.06%
|
3.65
|
| Proceeds From Stock Option Exercised |
|
0.90
+3442.09%
|
0.03
|
0.00
-100.00%
|
0.37
|
| Changes In Cash |
|
0.51
+257.70%
|
0.14
+102.54%
|
-5.59
-26.78%
|
-4.41
|
| Beginning Cash Position |
|
0.23
+157.86%
|
0.09
-98.41%
|
5.68
-43.70%
|
10.10
|
| End Cash Position |
|
0.74
+218.98%
|
0.23
+157.86%
|
0.09
-98.41%
|
5.68
|
| Free Cash Flow |
|
-3.16
+39.26%
|
-5.20
+21.41%
|
-6.62
-2.03%
|
-6.48
|
| Interest Paid Supplemental Data |
|
0.21
+2127.61%
|
0.01
|
0.00
-100.00%
|
0.05
|
| Income Tax Paid Supplemental Data |
|
0.00
|
0.00
-100.00%
|
0.00
-75.81%
|
0.00
|
| Change In Income Tax Payable |
|
—
|
—
|
0.00
+100.00%
|
-0.00
|
| Change In Interest Payable |
|
0.17
+36.85%
|
0.12
+7731.88%
|
0.00
-92.56%
|
0.02
|
| Change In Tax Payable |
|
—
|
—
|
0.00
+100.00%
|
-0.00
|
| Common Stock Issuance |
|
0.17
-97.10%
|
5.70
+1867.55%
|
0.29
-92.06%
|
3.65
|
| Earnings Losses From Equity Investments |
|
-0.01
-115.01%
|
0.06
-69.95%
|
0.20
-38.77%
|
0.33
|
| Issuance Of Capital Stock |
|
1.81
-68.27%
|
5.70
+1867.55%
|
0.29
-92.06%
|
3.65
|
| Net Preferred Stock Issuance |
|
1.64
|
0.00
|
—
|
—
|
| Preferred Stock Issuance |
|
1.64
|
0.00
|
—
|
—
|
| Sale Of Business |
|
0.47
|
0.00
|
—
|
—
|
SEC Filings
Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.
- 8-K2026-03-31 View
- 8-K2026-02-24 View
- 8-K2026-01-30 View
- 8-K2026-01-26 View
- 8-K2026-01-06 View
- 8-K2025-12-17 View
- 42025-12-05 View
- 8-K2025-12-05 View
- 8-K2025-12-03 View
- 8-K2025-11-17 View
- 10-Q2025-11-17 View
- 8-K2025-10-22 View
- 8-K2025-10-10 View
- 8-K2025-10-03 View
- 42025-10-03 View
- 8-K2025-09-29 View
- 8-K2025-09-26 View
- 8-K2025-09-12 View
- 8-K2025-09-05 View
- 42025-08-28 View
Trades
| Date | User | Broker | Pattern | Type | Position Size | Entry Price | Trade P&L | Status |
|---|
Posts
| Published | Title | Author | Category |
|---|